Literature DB >> 2717533

Fetal liver alanine: glyoxylate aminotransferase and the prenatal diagnosis of primary hyperoxaluria type 1.

C J Danpure1, P R Jennings, R J Penketh, P J Wise, P J Cooper, C H Rodeck.   

Abstract

Primary hyperoxaluria type 1 (PH1) is caused by a deficiency of the hepatic peroxisomal enzyme alanine: glyoxylate aminotransferase (AGT, EC 2.6.1.44) (Danpure and Jennings, FEBS Lett., 201, 20-24, 1986). The activity of AGT has been measured in fetal livers of gestational age 14-21 weeks. Activity increases up to 17 weeks and then levels off between 17 and 21 weeks. At this time, the mean AGT activity is about 30 per cent of the mean normal postnatal level. As in adult liver, the AGT enzyme activity and the AGT immunoreactive protein are peroxisomal. Prenatal diagnosis has been performed by measuring AGT enzyme activity and immunoreactive AGT protein on liver biopsies from two fetuses at risk for primary hyperoxaluria type 1. One was unaffected and one was affected.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2717533     DOI: 10.1002/pd.1970090406

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  7 in total

Review 1.  Fetal drug metabolism and its possible clinical implications.

Authors:  B Krauer; P Dayer
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

Review 2.  Prenatal diagnosis of enzyme defects.

Authors:  B Winchester
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

Review 3.  What are the present possibilities for the prenatal diagnosis of primary hyperoxaluria?

Authors:  C J Danpure
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

Review 4.  Recent advances in the understanding, diagnosis and treatment of primary hyperoxaluria type 1.

Authors:  C J Danpure
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

5.  Enzymatic prenatal diagnosis of primary hyperoxaluria type 1: potential and limitations.

Authors:  C J Danpure; P J Cooper; P R Jennings; P J Wise; R J Penketh; C H Rodeck
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

6.  Molecular characterization and clinical use of a polymorphic tandem repeat in an intron of the human alanine:glyoxylate aminotransferase gene.

Authors:  C J Danpure; G M Birdsey; G Rumsby; M J Lumb; P E Purdue; J Allsop
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

7.  Gene therapy of Csf2ra deficiency in mouse fetal monocyte precursors restores alveolar macrophage development and function.

Authors:  Fengqi Li; Katarzyna Maria Okreglicka; Federica Piattini; Lea Maria Pohlmeier; Christoph Schneider; Manfred Kopf
Journal:  JCI Insight       Date:  2022-04-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.